Back to Directory
PulmoBioMed
Founded 2020
No longer trading
Creditors' voluntary liquidation began 8 Jul 2026.
Non-invasive deep lung breath sampling device for molecular research
PulmoBioMed is a medical technology company developing a handheld device for collecting exhaled breath condensate from the lower respiratory tract without contamination from the upper airway or oral cavity.
The device provides uncontaminated lung-derived samples for downstream molecular analysis including proteomics, metabolomics, microbiology, and nucleic acid profiling.
Applications span respiratory disease diagnosis, pulmonary biomarker discovery, antimicrobial resistance research, pharmacokinetics, and toxicology screening.
A clinical configuration targets point-of-need asthma diagnosis.
Company Notes
Member of